SHSE:603127 (China)
Â
Class A
Â¥
41.54
+1.49 (+3.72%)
Jul 31
Business Description
Joinn Laboratories (China) Co Ltd
ISIN : CNE100002W27
Share Class Description:
SHSE:603127: Class ATotal Employee Number:
2,649Compare
Compare
Traded in other countries / regions
603127.China06127.Hong Kong Index Membership
SSE Composite IndexCSI 500 Index IPO Date
2017-08-25Description
Joinn Laboratories (China) Co Ltd is a PRC-based company, along with its subsidiary, it is engaged in contract research organisation (CRO) services. It operates in three segments: Non-clinical studies services offer drug safety assessment, drug metabolism and pharmacokinetics (DMPK) studies, and pharmacology and efficacy studies; Clinical trial & related services provide clinical CRO services, co-managed phase I clinical research units, and bioanalytical servicesl services; and Sales of research models engages in the design, production, breeding and sales of research models, non-human primates and rodents. The majority of revenue comes from the Non-Clinical studies services. Its geographical areas are China, the United States, and Other countries, of which the majority are from China.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 67.41 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-EBITDA | 0.07 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 12.71 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.7 | |||||
3-Year EBITDA Growth Rate | -29 | |||||
3-Year EPS without NRI Growth Rate | -32.4 | |||||
3-Year FCF Growth Rate | -24.2 | |||||
3-Year Book Growth Rate | 0.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 38.53 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 20.22 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.15 | |||||
9-Day RSI | 42.68 | |||||
14-Day RSI | 46.88 | |||||
3-1 Month Momentum % | -1.67 | |||||
6-1 Month Momentum % | 0.55 | |||||
12-1 Month Momentum % | 19.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.02 | |||||
Quick Ratio | 2.78 | |||||
Cash Ratio | 1.98 | |||||
Days Inventory | 409.85 | |||||
Days Sales Outstanding | 36.85 | |||||
Days Payable | 14.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Dividend Payout Ratio | 0.65 | |||||
3-Year Dividend Growth Rate | -51.1 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 0.16 | |||||
Shareholder Yield % | 0.4 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.32 | |||||
Operating Margin % | -3.29 | |||||
Net Margin % | 29.36 | |||||
EBITDA Margin % | 32.34 | |||||
FCF Margin % | 2.43 | |||||
OCF Margin % | 30.07 | |||||
ROE % | 6.01 | |||||
ROA % | 5.14 | |||||
ROIC % | -0.72 | |||||
3-Year ROIIC % | -267.49 | |||||
ROC (Joel Greenblatt) % | 20.87 | |||||
ROCE % | 6.45 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 62 | |||||
Forward PE Ratio | 80.19 | |||||
PE Ratio without NRI | 903.04 | |||||
Shiller PE Ratio | 83.12 | |||||
Price-to-Owner-Earnings | 149.42 | |||||
PS Ratio | 18.06 | |||||
PB Ratio | 3.64 | |||||
Price-to-Tangible-Book | 3.79 | |||||
Price-to-Free-Cash-Flow | 680.98 | |||||
Price-to-Operating-Cash-Flow | 60.03 | |||||
EV-to-EBIT | 47.69 | |||||
EV-to-Forward-EBIT | 15.15 | |||||
EV-to-EBITDA | 47.69 | |||||
EV-to-Revenue | 15.42 | |||||
EV-to-Forward-Revenue | 3.1 | |||||
EV-to-FCF | 634.93 | |||||
Price-to-GF-Value | 2.38 | |||||
Price-to-Projected-FCF | 3.06 | |||||
Price-to-Graham-Number | 12.33 | |||||
| Price-to-Net-Current-Asset-Value | 8.67 | |||||
| Price-to-Net-Cash | 30.77 | |||||
Earnings Yield (Greenblatt) % | 2.1 | |||||
FCF Yield % | 0.14 | |||||
Forward Rate of Return (Yacktman) % | -22.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Joinn Laboratories (China) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,686.422 | ||
| EPS (TTM) (Â¥) | 0.67 | ||
| Beta | 2.1174 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 0.61 | ||
| Volatility % | 45.25 | ||
| 14-Day RSI | 46.88 | ||
| 14-Day ATR (Â¥) | 3.940268 | ||
| 20-Day SMA (Â¥) | 45.022 | ||
| 12-1 Month Momentum % | 19.77 | ||
| 52-Week Range (Â¥) | 26.25 - 55.68 | ||
| Shares Outstanding (Mil) | 749.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Joinn Laboratories (China) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Joinn Laboratories (China) Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.120000 Cash Dividend | 2026-06-30 | 39.60 (+6.80%) | ||
| CNY 0.030000 Cash Dividend | 2025-08-14 | 34.20 (+9.62%) | ||
| 1.4:1 Stock Split | 2023-07-25 | 26.59 (+0.24%) | ||
| 1.4:1 Stock Split | 2022-08-08 | 61.08 (+0.71%) | ||
| 1.4:1 Stock Split | 2021-08-05 | 83.70 (+8.56%) | ||
| 1.4:1 Stock Split | 2020-06-08 | 33.84 (+0.78%) | ||
| 1.4:1 Stock Split | 2019-04-10 | 12.74 (-0.72%) | ||
| 1.4:1 Stock Split | 2018-05-31 | 10.89 (+2.74%) |
Show
Entries
Joinn Laboratories (China) Co Ltd Frequently Asked Questions
What is Joinn Laboratories (China) Co Ltd(SHSE:603127)'s stock price today?
The current price of SHSE:603127 is ¥41.54. The 52 week high of SHSE:603127 is ¥55.68 and 52 week low is ¥26.25.
When is next earnings date of Joinn Laboratories (China) Co Ltd(SHSE:603127)?
The next earnings date of Joinn Laboratories (China) Co Ltd(SHSE:603127) is .
Does Joinn Laboratories (China) Co Ltd(SHSE:603127) pay dividends? If so, how much?
The Dividend Yield %  of Joinn Laboratories (China) Co Ltd(SHSE:603127) is 0.29% (As of Today), Highest Dividend Payout Ratio of Joinn Laboratories (China) Co Ltd(SHSE:603127) was 5.33. The lowest was 0.07. And the median was 0.21. The  Forward Dividend Yield % of Joinn Laboratories (China) Co Ltd(SHSE:603127) is 0.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Joinn Laboratories (China) Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers